Sanuwave terminates CCO Nanci Gilmore, appoints Dustin Libby as EVP of Commercial Operations

SANUWAVE Health, Inc.

Nanci Gilmore terminated without cause as CCO on May 30, 2025; eligible for $97,916.67 severance (5 months salary) subject to release.
Dustin Libby appointed EVP of Commercial Operations effective June 3, 2025; brings 20 years of medical device experience.
Libby previously at Abiomed, where he helped scale a $15M surgical business to over $500M in revenue.
CEO Morgan Frank cited Libby's experience in scaling teams and systems for the next growth phase.

item 5.02item 7.01item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Dustin Libby

Executive Vice President of Commercial Operations

SNWV · SANUWAVE Health, Inc.

Effective: 2025-06-03
Filed: Jun 03, 2025 23:59 UTC

In connection with Ms. Gilmore’s termination, Dustin Libby joined the Company as Executive Vice President of Commercial Operations on June 3, 2025.

Departed

Nanci Gilmore

Chief Commercial Officer

SNWV · SANUWAVE Health, Inc.

Effective: 2025-05-30
Successor: Dustin Libby
Filed: Jun 03, 2025 23:59 UTC

On May 30, 2025, Nanci Gilmore, the Chief Commercial Officer of Sanuwave Health, Inc. (the “Company”), was terminated without cause, effective as of the same date.

Source: SEC EDGAR

accession 0001628280-25-029114

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.